-Smooth-Muscle Actin Expression Are
Repressed by Particulate-Activated Macrophage-Derived
Tumor Necrosis Factor- in Experimental Silicosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Lung elastin synthesis is normally confined to periods of development, is maximal during alveolarization,
and declines to low levels in mature lung. We have previously described an elastogenic response in the
adult rat lung associated with experimental granulomatous disease induced by silica instillation. Reinitiated tropoelastin expression was identified throughout the lung in fibroblasts expressing
-smooth-muscle
actin, whereas fibroblasts within the granulomatous lesions failed to express both tropoelastin and
-smooth-
muscle actin (Mariani and colleagues, Am. J. Pathol. 1995;147:988-1000). We hypothesized that inflammatory cells within the granulomatous lesions produce factors that alter fibroblast phenotype. We found that macrophages accumulating within granulomatous lesions of silicotic rat lungs produce and secrete tumor necrosis factor (TNF)-
, a proinflammatory cytokine previously appreciated as a repressor of tropoelastin gene expression. In experimental cell systems, macrophages activated by particulates, either in
vivo or in vitro, conditioned medium with a tropoelastin-repressing activity. This activity repressed both
tropoelastin and
-smooth-muscle actin expression in primary cultures of rat lung fibroblasts in a time-
dependent, transient manner. The particulate-activated macrophage-conditioned medium was found to
contain TNF-
, which was both necessary and sufficient to induce these changes in lung fibroblast gene
expression. These data indicate that macrophage-derived factors can modulate lung fibroblast tropoelastin
expression in the diseased lung. Furthermore, the findings extend the association between expression by
lung fibroblasts of tropoelastin and
-smooth-muscle actin.
| |
Introduction |
|---|
|
|
|---|
Elastin is a major component of the lung extracellular matrix, and is essential for normal lung function. Elastic fibers, together with collagen fibers, form a continuous network throughout the lung that provides the forces necessary for passive expiration (1, 2). Lung elastic fibers are predominant in the vascular media and in the medial region of conducting airways; they also line the walls of terminal bronchioles and alveolar ducts and form ringlike structures at the entrances to individual alveoli. The physiologic importance of these fibers is exemplified by the direct association between their disruption and impaired lung function in emphysema (3).
Elastic fibers are now appreciated as highly complex
structures containing numerous protein and glycoprotein
components. The principal component of elastic fibers, by
weight, is the crosslinked form of the soluble protein tropoelastin. In the distal airways, tropoelastin is produced
primarily during the alveolarization stage of lung development, by mesenchymal cells positive for
-smooth-muscle actin (
-SMA), located at sites of secondary crest formation (4). Gene-deletion studies have suggested a direct
correlation between the differentiation of these cells from
undifferentiated mesenchymal precursors and the production of elastin in the developing lung (7). In the adult lung,
-SMA-expressing fibroblasts are seen at alveolar septal
tips (8), but tropoelastin expression is rarely seen because
of the stability of mature elastic fibers (9). Developmental
induction of lung tropoelastin expression occurs at the
level of gene transcription, whereas posttranscriptional mechanisms are involved in its cessation (10).
We have previously described an elastogenic response
to silica instillation in an experimental model of granulomatous inflammation of the lung (8). This elastogenic response is complex, with developing granulomatous lesions
devoid of elastin gene expression, and peripheral, uninvolved airways showing renewed elastin production and
accumulation. Because fibrotic cells typically found in lung pathologies express
-SMA (11, 12), we sought to investigate the mechanism(s) responsible for the coordinate lack
of tropoelastin and
-SMA expression within silicotic rat
lung granulomas. We have previously shown that silicotic
granulomas are rich in infiltrating, activated macrophages
releasing cytokines that alter the phenotype of adjacent
mesenchymal cells (13, 14). Here we report that particulate-activated macrophages produce and secrete tumor necrosis factor (TNF)-
, which suppresses tropoelastin gene
expression in vivo and transcription in vitro. Furthermore,
we found a correlated repression of
-SMA gene expression. These data extend the association between
-SMA
and tropoelastin gene expression in the diseased lung, and
provide insight into the mechanism of their coordinate regulation. The data also identify TNF-
as a physiologic
repressor of endogenous tropoelastin expression during
inflammatory lung disease.
| |
Materials and Methods |
|---|
|
|
|---|
Animals and Reagents
Normal adult (250 g) Sprague-Dawley rats were purchased from Charles River (Cambridge, MA). Silica (Min-U-Sil; 5 µm) was purchased from U.S. Silica (Berkley
Springs, WV) and rendered endotoxin-free by boiling in
acid. The murine monocytic cell line J774.1 was obtained
from the American Type Culture Collection (Rockville, MD). Zymosan and pepsin were obtained from Sigma
Chemical Co. (St. Louis, MO). Murine TNF-
, (IL)-interleukin-1
, TNF-
and IL-1
-neutralizing antibodies, and
soluble TNF-
-receptor (sTNF-R) were purchased from
R&D Systems (Minneapolis, MN).
In Situ Hybridization and Immunostaining
In situ hybridization was performed on lung sections from
normal adult rats (250 g), rats receiving a single intratracheal instillation of 0.4 ml sterile saline containing 16 mg
silica (Min-U-Sil; 5 µm), or rats receiving a single intratracheal instillation of 0.4 ml sterile saline as a vehicle control
7 d before being killed. A detailed description of the induction of silicosis and the methods used for in situ hybridization have previously been published (8, 13). Antisense
probes for rat tropoelastin were generated from the complementary DNA (cDNA) pREL124DM. Immunostaining was performed with a Vectastain immunostaining kit (Vector
Laboratories, Burlingame, CA) according to the manufacturer's instructions. Antibody clone ED1 (Harlan Inc.,
Indianapolis, IN) was used to identify monocyte/macrophage cells. Detection of TNF-
was done with a commercially available antibody for murine TNF-
(R&D Systems).
Cell Culture
Primary macrophages were obtained by bronchoalveolar lavage (BAL) from healthy or silicotic adult rat lungs 7 d after instillation of saline or silica, respectively. Briefly, animals were killed with a lethal dose of sodium pentobarbital. The trachea was cannulated and the pulmonary circulation was washed free of blood with saline. The lungs were removed from the thoracic cavity and lavaged repeatedly with a single 10-ml aliquot of normal saline. After lavage, the saline was collected and centrifuged at 500 × g for 5 min at 4°C. The cell pellet was resuspended in culture medium (Dulbecco's modified Eagle's medium supplemented with 10% calf serum, nonessential amino acids, L-glutamine, and antibiotics), and nucleated cells were counted with a hemocytometer. Cells were plated on tissue-culture-treated plastic dishes at a concentration of 0.5 × 106 cells/ml and were allowed to adhere overnight. On the following day the culture dishes were washed to remove dead cells, and the remaining cells were refed with culture medium. Lavaged cells in medium-conditioning cultures consisted of more than 95% macrophages as assessed by ED1 staining. J774 cells were plated at a concentration of 0.5 × 106 cells/ml and allowed to adhere overnight. On the following day, J774 cells were washed with phosphate-buffered saline and refed with culture medium. Lung fibroblasts were isolated from normal adult rats as previously described (10). Lung fibroblast gene expression was assessed in early-passage confluent cultures.
Isolation of Cells and Application of Conditioned Medium
Primary macrophages or J774 cells were washed and refed with culture medium in the absence or presence of silica (0.1 mg/ml; 12.5 µg/cm2) or zymosan (4 mg/ml; 0.5 mg/ cm2). Conditioned medium was harvested after 24 h and centrifuged to pellet particulates and cell debris. The supernatant was transferred to a sterile tube and stored at 4°C. The conditioned medium was filter-sterilized through a 0.2-µm syringe filter (Gelman Sciences, Ann Arbor, MI) prior to application to fibroblasts.
Confluent plates of lung fibroblasts at Passage 3 were washed with phosphate-buffered saline and refed with culture medium or with medium supplemented with 50% macrophage-conditioned medium. Treatment with conditioned medium was for 6-96 h, with changes of medium every 48 h. Replicate plates of lung fibroblasts were treated directly with silica (0.1 mg/ml; 12.5 µg/cm2) or zymosan (4 mg/ml; 0.5 mg/cm2) as controls. For serum-free experiments, all cells were grown as described previously, but the conditioning and treatment media used were serum-free. For each assay, at least three separate cultures of mesenchymal cells were treated as described and examined for extracellular matrix gene expression to ensure reproducibility.
Northern Blot Analysis
RNA isolation and Northern blot analysis were performed as previously described (15). Briefly, total RNA was isolated from cultured cells using a modified guanidine-phenol method. Five micrograms of total RNA were denatured by incubation for 10 min at 68°C in 50% formamide, 1 M formaldehyde, and 50 ng/ml ethidium bromide, and was separated by electrophoresis in a 1% agarose gel containing 1 M formaldehyde. RNA was transferred to Hybond N+ filters (Amersham, Arlington Heights, IL). Rat tropoelastin messenger RNA (mRNA) was detected with a purified insert DNA derived from the clone described earlier for in situ hybridization analysis. Clone pRGAPDH13 was used for the detection of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as a control (9, 12). The cDNA probe for actin was obtained from Clontech (Palo Alto, CA).
Assessment of Tropoelastin Gene Transcription Rate
Levels of tropoelastin pre-mRNA in fibroblast cultures were measured as a reflection of the transcription rate for the tropoelastin gene, according to the method of Swee and colleagues (16). Briefly, total RNA isolated for Northern blot analysis was digested with ribonuclease-free deoxyribonuclease to remove residual genomic DNA, reverse-transcribed with random hexamers to make cDNA, and amplified with the polymerase chain reaction (PCR), using tropoelastin intron-specific primers (5'-GTCAGAGGTCAAGGTCTAGG-3' and 5'-TCAGTCTAGACATGCAACAC-3'). Amplification was optimized for template concentration and cycle number, and was determined to be within a linear range. Amplification products were separated in a 1.2% agarose gel, blotted to Hybond N+ filters and probed with [32P]deoxycytosine triphosphate ([32P]dCTP)-labeled internal oligonucleotide primer (5'- GACATACCACCAGGTGGCGC-3'). After stringent washing, the hybridized blot was exposed for various periods of time to X-ray film. Autoradiograms were scanned and digitally captured in a Power Macintosh computer (Apple, Inc., Cupertino, CA), and were quantified by comparing the mean pixel density of each band using the NIH Image program (National Institutes of Health, Bethesda, MD). Control reactions lacking reverse transcriptase were performed to rule out contamination of RNA by genomic DNA. Amplification of GAPDH mRNA from the fibroblast RNA samples was used to control for template concentration loading.
Analysis of the Role of TNF-
in
Conditioned Medium
To characterize macrophage-derived activity, serum-free, zymosan-activated J774-conditioned medium was subjected to various treatments. Acid lability was determined by adjusting the pH of the conditioned medium to 2.5 with 0.5 N HCl, incubating for 2 h at 37°C, and neutralizing with 0.5 N NaOH. Pepsin sensitivity was tested by following the same procedure, with the inclusion of 0.2 mg/ml pepsin. After each treatment, the conditioned medium was dialyzed against serum-free culture medium and filter sterilized before being added to fibroblasts.
To investigate the effects of TNF-
on rat tropoelastin
gene expression, primary cultures of lung fibroblasts were
treated with 20 ng/ml recombinant murine TNF-
for 48 h.
The role of TNF-
in the zymosan-activated J774-conditioned medium was assessed by neutralization with a murine TNF-
neutralizing antibody. Fifty percent zymosan-activated, J774-conditioned medium was incubated with
10 µg/ml anti-TNF-
antibody for 2 h at 37°C with gentle shaking. Identical treatment of conditioned medium with a
murine IL-1
-neutralizing antibody (10 µg/ml) served as a control.
| |
Results |
|---|
|
|
|---|
TNF-
Is Present in Developing
Granulomatous Lesions
We have previously shown that developing granulomatous
lesions in an experimental model of rat lung silicosis containing macrophages are devoid of de novo elastin production and contain no
-SMA-expressing cells (8, 13). Previous reports have suggested that similar lesions were rich
in the proinflammatory cytokine TNF-
(17, 18). Since
this cytokine has been shown to be capable of inhibiting tropoelastin expression (19), we chose to assess TNF-
production in our model of rat lung silicosis, and its association with tropoelastin expression. In situ hybridization for
tropoelastin mRNA (Figures 1A and 1B) showed that tropoelastin expression was abundant peripherally to developing silicotic lesions, but absent within them. Immunohistochemistry for
-SMA (Figure 1C) and macrophage
marker antibody clone ED1 (Figure 1D) confirmed that
these lesions were rich in infiltrating lung macrophages,
but contained no
-SMA-expressing mesenchymal cells.
Immunohistochemistry for TNF-
(Figure 1E) revealed
abundant staining for TNF-
within these granulomatous
lesions in both cell-associated and matrix-associated patterns. Dual immunostaining for TNF-
and macrophages
(Figure 1F) showed that macrophages were abundant in
the regions of granulomas rich in TNF-
. Higher magnification views of sections stained for both TNF-
alone
(Figure 1G) or TNF-
and ED1 (Figure 1H) revealed that
the cell-associated pattern of TNF-
-staining colocalized
with macrophage cells. This strongly suggests that the infiltrating macrophages produced and secreted the antielastogenic cytokine TNF-
within developing silicotic granulomas. Alveolar macrophages (AM) distant from sites of
granulomas also stained positively for TNF-
(data not
shown).
|
Particulate-Activated Macrophages Repress Lung Fibroblast Tropoelastin Expression
In order to confirm and mechanistically explore the association between infiltrating macrophage TNF-
production
within silicotic lung granulomas and tropoelastin gene expression, we sought to develop an in vitro model (Figure
2). Initially, we isolated particulate-activated macrophages
from silicotic rat lungs by BAL, allowed these cells to condition medium in culture, and assessed the effects of this medium on primary cultures of rat lung fibroblasts. As
shown in Figure 2A, medium conditioned by macrophages
isolated from silicotic lungs dramatically repressed lung fibroblast tropoelastin mRNA levels. This was not due to a
generalized inhibition of gene expression, as evidenced by
the previously described induction of collagenase-3 mRNA
levels under the same conditions (14). These data indicate that macrophages activated by particulate silica in vivo
elaborate factor(s) that specifically repress tropoelastin
gene expression.
|
We next determined whether we could activate normal rat lung macrophages in vitro such that they would produce the tropoelastin-repressing factor. Macrophages were isolated from normal, healthy rat lungs through BAL, and were placed in culture. These cells were allowed to condition medium in the absence or presence of particulate stimulants. As shown in Figure 2B, unstimulated healthy rat lung macrophage-conditioned medium had no effect on lung fibroblast tropoelastin mRNA levels. However, macrophages stimulated in vitro with silica (0.1 mg/ml; 12.5 µg/cm2) or zymosan (4 mg/ml; 0.5 mg/cm2) elaborated factor(s) that repressed tropoelastin expression in lung fibroblasts. Zymosan, a yeast cell-wall-derived particulate that stimulates phagocytosis, was a more potent activator of production/secretion of this activity than was silica in vitro.
Additionally, we tested the ability of the monocytic J774 cell line to respond to particulates in a similar fashion. Again, unstimulated J774-cell conditioned medium had no effect on lung fibroblast tropoelastin expression, whereas particulate-activated J774 cells elaborated factor(s) that repressed tropoelastin expression (Figure 2C). The J774 cells were unresponsive to silica in vitro, as has been previously observed (20). Nonetheless, zymosan-stimulated J774-cell-conditioned medium had tropoelastin- repressing activity identical to that observed for silicotic rat lung macrophage-conditioned medium. Zymosan-stimulated J774-conditioned medium also induced expression of the gene for lung fibroblast collagenase-3 (14). These data indicate that the conditioned medium from the different macrophage sources, whether these cells were activated in rat lungs by silica or by zymosan in vitro, was functionally equivalent. Macrophage cell death was not noted in cultures, and is apparently not involved in the production/release of the observed activity.
Macrophages Coordinately Repress Tropoelastin
and
-SMA Expression
We chose to further explore the temporal nature of the macrophage-dependent repression of tropoelastin gene expression in lung fibroblasts. As shown in Figure 3, this repression occurred relatively slowly over time, with effects first prominent at 24 h of treatment and maximal at 48 h of treatment. Conversely, our previously observed induction of collagenase-3 gene expression occurred much more rapidly (14). We further assessed whether this alteration in tropoelastin gene expression was epigenetic or transient. Lung fibroblasts were treated with conditioned medium for 48 h and then washed and refed with normal medium for another 48 h. After removal of conditioned medium, the fibroblasts reverted to their original gene- expression profile, showing increased tropoelastin expression and no collagenase-3 expression, indicating that the effects of the activity were not phenotypically stable. We also found that repression of tropoelastin expression (like induction of collagenase-3 expression) was dependent on new protein synthesis (data not shown).
|
Characteristic fibrotic lung lesions are composed of
-SMA-expressing "activated myofibroblasts," which accumulate matrix (11, 12). However, in silica-induced lung
fibrosis, the fibrotic cells do not express
-SMA (8). Mesenchymal cell (myofibroblast) tropoelastin expression appeared to be linked to
-SMA expression both in our experimental rat lung silicosis model and in numerous other
in vivo and in vitro situations (7, 21). Cumulatively, these
data suggest that an
-SMA-expressing phenotype is permissive for tropoelastin expression in lung fibroblasts.
Therefore, we assessed the level of
-SMA expression in
our lung fibroblasts in both the absence and presence of
tropoelastin-repressing macrophage-conditioned medium.
As shown in Figure 3,
-SMA mRNA levels were repressed by this conditioned medium, with a time-course
similar to that for tropoelastin mRNA repression. Similarly, immunocytochemistry suggested a decrease in the
polymerization state of
-SMA in lung fibroblasts treated
with conditioned medium (data not shown). This coordinate regulation of tropoelastin and
-SMA in lung fibroblast cultures paralleled our in vivo observations.
Macrophage-Derived Tropoelastin Repression Occurs at the Level of Gene Transcription
In the lung, repression of tropoelastin expression by various factors has been shown to occur both at the level of
gene transcription and posttranscriptionally (19). Therefore, we assessed the mechanism of tropoelastin repression effected by medium conditioned by particulate-activated macrophages. These studies made use of a previously
published reverse transcription (RT)-PCR-based assay specific for the detection of tropoelastin pre-mRNA levels
(16, 22). As shown in Figure 4, the tropoelastin-repressing
conditioned medium substantially decreased tropoelastin
gene transcription, as evidenced by decreased steady-state
levels of tropoelastin pre-mRNA. Fibroblasts treated with
conditioned medium contained approximately one-third
the steady-state levels of tropoelastin pre-mRNA as untreated cultures. The previously characterized tropoelastin
transcriptional repressors TNF-
or IL-1
, administered
to lung fibroblast cultures individually or in combination,
produced a similar level of inhibition. These data indicate
that medium conditioned by particulate-activated macrophages represses tropoelastin gene expression primarily
at the level of gene transcription.
|
Macrophage-Derived TNF-
Is
Necessary and Sufficient
We sought to determine the molecular nature of the factor(s) present in particulate-activated macrophage-conditioned medium that acted to repress tropoelastin gene expression. Initially, we tested the ability of J774 cells to
elaborate this factor(s) and the ability of the rat lung fibroblasts to respond to it in serum-free conditions. As shown
in Figure 5A, the absence of serum had no effect on the
ability of the conditioned medium to repress tropoelastin
and
-SMA gene expression (lanes 1 and 2). Next, we manipulated the conditioned medium before presenting it to the fibroblasts. Figure 5A also shows that the repressing
activity of the conditioned medium was sensitive to pepsin
digestion (lane 3), but resistant to acidification (lane 4).
These data strongly suggested that the activity was proteinaceous.
|
As TNF-
is a known inhibitor of tropoelastin gene
transcription and is present within nonelastogenic regions
of silicotic granulomas in vivo, we investigated its role in
our in vitro system. As was the case with silicotic rat lung
granuloma-infiltrating macrophages in vivo, particulate-stimulated AM and J774 cells stained positively for TNF-
(data not shown). Furthermore, we and others have previously shown that TNF-
is specifically induced in monocytic J774 cells by stimulation with zymosan, but not silica, in vitro (12, 15). As seen in Figure 5B, purified recombinant TNF-
showed a similar tropoelastin-repressing
activity in our primary cultures of rat lung fibroblasts to
that shown by the particulate-activated macrophage-conditioned medium (Figure 5B, lanes 2 and 3). We have recently shown that in this model system, collagenase-3 induction by particulate-activated magrophage-conditioned medium is due to the combined effects of TNF-
and secreted arachidonate metabolites (14). Given the differences in kinetics between collagenase-3 induction and tropoelastin repression (Figure 3), it was uncertain whether a
similar mechanism was involved in the present study.
Next, we performed antibody neutralization experiments
on the particulate-activated macrophage-conditioned medium, in order to assess the role of TNF-
and IL-1
, two
proinflammatory, tropoelastin-repressing cytokines. As seen
in Figure 5B, TNF-
-neutralizing antibody at 10 µg/ml
completely abrogated the tropoelastin-repressing activity of the conditioned medium (Figure 5B, lane 4). However,
a similar amount of IL-1
-neutralizing antibody had no
effect on the ability of the conditioned medium to inhibit
tropoelastin expression (Figure 5B, lane 5). Similar neutralization of the activity of the conditioned medium was
achieved with a commercially available, soluble TNF-
receptor (data not shown). These data indicate that TNF-
is
both necessary and sufficient for the macrophage-mediated repression of tropoelastin gene expression. As in the
case of tropoelastin gene expression, TNF-
neutralization, but not IL-1
neutralization, abrogated the
-SMA-
repressing activity of the conditioned medium (data not
shown). These data extend the relationship between tropoelastin expression and
-SMA expression to this model,
with relevance to elastin regulation in adult lung disease.
| |
Discussion |
|---|
|
|
|---|
We have previously reported an elastogenic response in an
experimental model of lung disease (8). In this model,
granulomatous inflammation was incited by a single intratracheal instillation of silica. This led to frank fibrosis as
assessed by increases in lung weight as well as in DNA, total protein, and collagen content. The elastogenic response
in this model was complex and highly localized. New elastin synthesis and accumulation was observed throughout
the entire rodent lung, from
-SMA-containing cells at
sites reminiscent of those involved in elastin production
during development. Although cell proliferation and collagen accumulation occurred primarily within the granulomatous lesions (13), no elastin was produced within these
lesions. This lack of expression was particularly intriguing,
given that each lesion probably involved numerous alveolar septae, which are sites of
-SMA-containing and tropoelastin-expressing cells. In an effort to determine the mechanisms responsible for regulating tropoelastin expression in this model, we investigated the production of
known inflammatory mediators and tropoelastin gene regulators in vivo. We identified abundant production and
secretion of the tropoelastin repressor TNF-
by infiltrating macropohages found within developing granulomas. Therefore, we assessed the ability of macrophages to respond to particulates by secreting TNF-
, which could repress tropoelastin gene expression by lung fibroblasts.
Using various cell culture model systems, we found that
primary AM responded to particulates both in vivo and in
vitro by secreting a tropoelastin-repressing activity in lung
fibroblasts. Further, the murine monocytic J774 cell line
responded to particulate zymosan in vitro by producing
TNF-
, which is both necessary and sufficient to emulate
the tropoelastin-repressing activity. Interestingly, this activity simultaneously repressed lung fibroblast
-SMA expression. We have recently described a similar mechanism
that is responsible for the macrophage-dependent induction of lung fibroblast collagenase-3 gene expression in
this model (14). The regulation of the tropoelastin gene in
this model occurs at the level of gene transcription, as evidenced by our RT-PCR data (Figure 4). Furthermore, we
have previously shown that the macrophage-conditioned
medium producing this effect induces fos-related AP-1
binding in rat lung fibroblasts (14), which has previously
been shown to be involved in repressing tropoelastin gene
transcription (23). The longer lag time needed for a maximal response in the case of tropoelastin gene regulation (Figure 3) relative to collagenase-3 induction is probably
due to the long half-life of tropoelastin mRNA. Taken together, our data indicate that factors elaborated by particulate-activated macrophages can elicit characteristics representative of lung granuloma fibroblasts.
Macrophages obtained from various sites within the
lung may not be identical. For instance, the macrophages
isolated from silicotic rat lungs by BAL may be somewhat
different from those found within the granulomatous lesions themselves. Even so, both these populations of macrophages, along with both AM isolated from normal rat
lungs and the J774 cell line, responded to particulates by
producing TNF-
. Although conditioned medium produced by macrophages isolated from silicotic rat lungs potently repressed tropoelastin expression by lung fibroblasts, normal AM stimulated in vitro with silica were less
able to do so. Stimulation of normal macrophages and the
J774 cell line with zymosan, a yeast cell-wall-derived particulate, duplicated the activity released by silicotic lung macrophages and induced expression of TNF-
. Indeed, it
has previously been shown that the J774 cell line will respond to zymosan but not to silica in vitro by producing
TNF-
(20). It is likely that in vivo, granuloma macrophages phagocytose not only silica, but also cellular and
extracellular matrix debris. Although other interpretations
are possible, these data led us to hypothesize that an unidentified costimulator found in the silicotic lung, which is
absent in our in vitro systems, is responsible for complete macrophage activation and induction of inflammatory cytokine production.
TNF-
can have pleiotropic effects on various cell types.
It has been reported to have either inductive or inhibitory
effects on cell proliferation. In fact, particulate-activated-macrophage-conditioned medium also inhibits lung fibroblast DNA synthesis by an undefined mechanism (our unpublished data). TNF-
can have diverse effects on cell
actin organization and gene expression, depending on cell type and culture conditions (24, 25). However, TNF-
has
been reported to destabilize actin mRNA in microvascular
endothelial cells (26). Our data implicate TNF-
as an inhibitor of
-SMA gene expression in lung fibroblasts. This
regulatory mechanism may be involved in the sequelae of
fibroblast alterations that occur during inflammatory lung disease.
In the developing lung, tropoelastin expression appears
to be restricted to cells that also express
-SMA. These include smooth-muscle cells producing elastic fibers in the
media of the vasculature and conducting airways, as well
as myofibroblasts producing elastic fibers of the lung interstitium (7, 27, 28). Others have previously reported the coordinate regulation of tropoelastin and
-SMA by lung fibroblasts in culture (21). Furthermore, transforming growth
factor-
, a potent inducer of tropoelastin expression, also
induces
-SMA expression in lung mesenchymal cells (29).
We observed previously that silicotic rat lung granuloma fibroblasts do not express
-SMA (8). We hypothesized
that these cells failed to participate in the elastogenic response of the silicotic lung because of their
-SMA-negative phenotype. Our current data suggest that macrophages
can secrete factors that act locally on lung fibroblasts to repress both tropoelastin and
-SMA gene expression. These
data extend the correlation between lung mesenchymal-cell
-SMA gene and tropoelastin gene expression, and further suggest that these genes are coordinately regulated in lung mesenchymal cells. Although TNF-
can repress
-SMA expression in lung fibroblasts, and the factor responsible for
-SMA repression by conditioned medium is
pepsin-labile (data not shown), the coordinate regulation
of
-SMA and tropoelastin in these cells may be mechanistically unrelated. However, because the expression of
the two genes is so closely linked in lung fibroblasts, we
propose that common regulatory pathways probably control their expression. Indeed, their coregulation by TNF-
supports this hypothesis.
| |
Footnotes |
|---|
Address correspondence to: Thomas J. Mariani, Ph.D., Department of Biochemistry and Molecular Biophysics, Box 8231, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. E-mail: mariani{at}biochem.wustl.edu
(Received in original form December 10, 1998 and in revised form February 3, 1999).
Abbreviations: alveolar macrophages, AM; interleukin, IL;
-smooth-muscle actin,
-SMA; tumor necrosis factor-
, TNF-
.
Acknowledgments: The authors thank Drs. Qinglang Li and Xueming Yi for assistance in isolating primary rat lung macrophages. We also are grateful to Drs. William Parks and Robert Mecham for helpful discussions and suggestions. This work was supported by National Institutes of Health grants HL-54049 (R.A.P.), HL-29594 (R.A.P.), and HL-09179 (T.J.M.), and by an American Lung Association Career Investigator Award (R.A.P.).
| |
References |
|---|
|
|
|---|
1.
Pierce, J. A., and
R. V. Ebert.
1965.
Fibrosis network of the lung and its
change with age.
Thorax
20:
469-476
2.
Mercer, R. R., and
J. D. Crapo.
1990.
Spatial distribution of collagen and
elastin fibers in the lungs.
J. Appl. Physiol.
69:
756-765
3. Janoff, A.. 1985. Elastases and emphysema. Am. Rev. Respir. Dis. 132: 417-433 [Medline].
4. Noguchi, A., and H. Samaha. 1991. Developmental changes in tropoelastin gene expression in the rat lung studied by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 5: 571-578 .
5. Noguchi, A., R. Reddy, J. D. Kursar, W. C. Parks, and R. P. Mecham. 1989. Smooth muscle isoactin and elastin in fetal bovine lung. Exp. Lung Res. 15: 537-552 [Medline].
6. McGowan, S. E.. 1992. Extracellular matrix and the regulation of lung development and repair. FASEB J. 6: 2895-2904 [Abstract].
7. Bostrom, H., K. Willets, M. Pekny, P. Leveen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellstrom, S. Gebremedhin, M. Schalling, M. Nilsson, S. Kurland, J. Tornell, J. K. Heath, and C. Betscholtz. 1996. PDGF-A signalling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85: 863-873 [Medline].
8. Mariani, T. J., E. Crouch, J. D. Roby, B. Starcher, and R. A. Pierce. 1995. Increased elastin production in experimental granulomatous lung disease. Am. J. Pathol. 147: 988-1000 [Abstract].
9. Shapiro, S. D., S. K. Endicott, M. A. Province, J. A. Pierce, and E. J. Campbell. 1991. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J. Clin. Invest. 87: 1828-1834 .
10.
Dunsmore, S. E.,
C. L. Osborne,
R. A. Goodman, and
D. E. Rannels.
1995.
Composition of the extracellular matrix of type II pulmonary epithelial
cells in primary culture.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
269:
L754-L765
11. Kuhn, C. 1993. The pathogenesis of pulmonary fibrosis. In The Lung: Current Concepts. A. Churg and A.-L. Katzenstein, editors. Williams & Wilkins, Baltimore. 78-92.
12. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145: 114-125 [Abstract].
13.
Mariani, T. J.,
J. D. Roby,
R. P. Mecham,
W. C. Parks,
E. Crouch, and
R. A. Pierce.
1996.
Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming
growth factor-
as a mediator of fibrosis.
Am. J. Pathol.
148:
151-164
[Abstract].
14.
Mariani, T. J.,
S. Sandefur,
J. D. Roby, and
R. A. Pierce.
1998.
Collagenase-3
induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-
and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury.
Mol. Biol. Cell.
9:
1411-1424
15.
Pierce, R. A.,
W. Mariencheck,
S. Sandefur,
E. C. Crouch, and
W. C. Parks.
1995.
Glucocorticoids upregulate tropoelastin expression during late
stages of fetal lung development.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
268:
L491-L500
16.
Swee, M.,
W. C. Parks, and
R. A. Pierce.
1995.
Developmental regulation of
elastin production. Expression of tropoelastin pre-mRNA persists after
downregulation of steady-state mRNA levels.
J. Biol. Chem.
270:
14899-14906
17. Gossart, S., C. Chambon, C. Orfila, M. H. Seguelas, J. C. Lepert, J. Rami, P. Carre, and B. Pipy. 1996. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. J. Immunol. 156: 1540-1548 [Abstract].
18. Davis, G. S., L. M. Pfeiffer, and D. R. Hemenway. 1998. Persistent overexpression of interleukin-1-beta and tumor necrosis factor-alpha in murine silicosis. J. Environ. Pathol. Toxicol. Oncol. 17: 99-114 [Medline].
19. Parks, W. C., R. A. Pierce, K. A. Lee, and R. P. Mecham. 1993. Elastin. In Advances in Molecular and Cell Biology, Vol. 6. H. K. Kleinman, editor. JAI Press, Greenwich, CT. 133-182.
20. Claudio, E., F. Segade, K. Wrobel, S. Ramos, and P. Lazo. 1995. Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death. Am. J. Respir. Cell Mol. Biol. 13: 547-554 [Abstract].
21.
McGowan, S. E.,
S. K. Jackson,
M. M. Doro, and
P. J. Olson.
1997.
Peroxisome proliferators alter lipid acquisition and elastin gene expression in
neonatal rat lung fibroblasts.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
273:
L1249-L1257
22.
Mariani, T. J.,
S. E. Dunsmore,
Q. Li,
X. Ye, and
R. A. Pierce.
1998.
Regulation of lung fibroblast tropoelastin expression by alveolar epithelial cells.
Am. J. Physiol. (Lung Cell. Mol. Physiol.)
274:
L47-L57
23.
Kahari, V. M.,
Y. Q. Chen,
M. M. Bashir,
J. Rosenbloom, and
J. Uitto.
1992.
Tumor necrosis factor-alpha down-regulates human elastin gene expression. Evidence for the role of AP-1 in the suppression of promoter activity.
J. Biol. Chem.
267:
26134-26141
24.
Goldblum, S. E.,
X. Ding, and
J. Campbell-Washington.
1993.
TNF-alpha
induces endothelial cell F-actin depolymerization, new actin synthesis, and
barrier dysfunction.
Am. J. Physiol.
264:
C894-C905
25. Wojciak-Stothard, B., A. Entwistle, R. Garg, and A. J. Ridley. 1998. Regulation of TNF-alpha induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and cdc42 in human endothelial cells. J. Cell. Physiol. 176: 150-165 [Medline].
26. Izumi, H., K. Shimizu, M. Ono, and M. Kuwano. 1993. Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp. Cell Res. 208: 498-503 [Medline].
27. Noguchi, A., and T. Nelson. 1991. IGF-I stimulates tropoelastin synthesis in neonatal rat pulmonary fibroblasts. Pediatr. Res. 30: 248-251 [Medline].
28. Mariani, T. J., S. Sandefur, and R. A. Pierce. 1997. Elastin in lung development. Exp. Lung Res. 23: 131-145 [Medline].
29. Mitchell, J. J., J. L. Woodcock-Mitchell, L. Perry, J. Zhao, R. B. Low, L. Baldor, and P. M. Absher. 1993. In vitro expression of the alpha-smooth muscle actin isoform by rat lung mesenchymal cells: regulation by culture condition and transforming growth factor-beta. Am. J. Respir. Cell Mol. Biol. 9: 10-18 .
This article has been cited by other articles:
![]() |
A. Churg, S. Zhou, X. Wang, R. Wang, and J. L. Wright The Role of Interleukin-1{beta} in Murine Cigarette Smoke-Induced Emphysema and Small Airway Remodeling Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 482 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Altiok, R. Yasumatsu, G. Bingol-Karakoc, R. J. Riese, M. T. Stahlman, W. Dwyer, R. A. Pierce, D. Bromme, E. Weber, and S. Cataltepe Imbalance between Cysteine Proteases and Inhibitors in a Baboon Model of Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 318 - 326. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |